Frailty was associated with a higher risk of urinary tract infections and other serious infections among kidney transplant recipients in studies discussed at IDWeek 2026. Yet a survey of transplant infectious diseases specialists found that only 40% routinely assessed frailty, according to Maricar Malinis, MD, medical director of the Transplant Infectious Disease Program at Vanderbilt University Medical Center.
Dr. Malinis emphasized the potential role of infectious diseases specialists in identifying vulnerable patients before transplantation, while noting that evidence is still needed to determine whether interventions targeting frailty can reduce infections.
Frailty describes diminished physiologic reserve and increased vulnerability to stressors. Although often associated with older age, it can also affect younger patients, making chronological age alone an incomplete measure of transplant-related risk.
Studies link frailty to infection risk
In a retrospective study published in Transplant Infectious Disease, 33 of 90 kidney transplant recipients (37%) aged 50 and older developed at least one urinary tract infection during a minimum of 12 months of follow-up. Recipients with frailty had a substantially higher hazard of UTI than those without frailty (hazard ratio, 8.13; 95% CI, 1.89-34.91).
The wide confidence interval indicated considerable uncertainty about the magnitude of the association. Among recipients with frailty, 12 of 21 UTI episodes (57%) occurred within 30 days after transplantation.
A larger retrospective analysis published in Scientific Reports also identified an association between frailty and severe infection among hospitalized kidney transplant recipients. The study included 185,742 hospitalizations involving adults with prior kidney transplants. Severe infection occurred in approximately 51% of hospitalizations in the highest Hospital Frailty Risk Score category, compared with 24% in the lowest category. After adjustment, the highest-risk group had more than three times the odds of severe infection (adjusted odds ratio, 3.18).
Both studies had important limitations. The smaller UTI study was conducted at a single center, while the hospitalization analysis relied on diagnostic coding and lacked transplant dates and pretransplant frailty measurements.
Dr. Malinis noted that much of the available evidence comes from small, single-center retrospective studies using different frailty assessment tools. Although the findings suggest that frailty may help identify patients at increased infection risk, they do not establish that frailty causes infection or that interventions targeting frailty will prevent it.
Frailty may also affect vaccine responses
Dr. Malinis also discussed research suggesting that frailty may be associated with weaker antibody responses to vaccination.
In a study of 101 kidney transplant recipients aged 70 and older without prior SARS-CoV-2 infection, 33% seroconverted after two doses of the BNT162b2 vaccine. Frailty was associated with lower odds of seroconversion (odds ratio, 0.14), according to findings published in International Urology and Nephrology.
These findings concerned antibody responses after vaccination, rather than differences in subsequent clinical infection rates, she noted.
Assessing frailty before transplantation
Given the associations between frailty and adverse outcomes, Dr. Malinis recommended assessing transplant candidates at listing and reassessing them at transplant admission.
Several assessment tools are available, although no single approach is considered the gold standard. The Fried frailty phenotype evaluates five characteristics: unintentional weight loss, exhaustion, low physical activity, slow gait and weak grip strength. The Liver Frailty Index measures grip strength, chair stands and balance.
Assessment may also help transplant teams identify deficits that could be addressed before surgery. Dr. Malinis described prehabilitation strategies involving exercise, nutritional interventions and psychosocial support, with particular attention to mobility, muscle strength and nutritional status.
She noted that some frailty associated with organ failure may improve after transplantation.
“[There’s a] strong message of the opportunity to prehabilitate these patients, optimize them for transplantation to change their outcomes. There is still a lot of work to be done for us to standardize frailty measurements across centers, integrate frailty into allocation algorithms in the future, distinguish aging frailty from disease-related debility and use frailty to guide individualized post-transplant care,” Dr. Malinis said.
Questions remain about infection prevention
Whether frailty assessments should influence antimicrobial prophylaxis, cytomegalovirus monitoring or other infection-prevention strategies remains uncertain. Dr. Malinis raised these possibilities as questions for further investigation, along with whether interventions involving exercise and nutrition could reduce infections.
For now, her recommendations focused on identifying frailty before transplantation, reassessing patients at admission and addressing measurable deficits in strength, mobility and nutrition. Additional studies are needed to determine whether frailty-guided interventions can improve infection outcomes.
Dr. Malinis had disclosed having no relevant conflicts of interest.